Hinshaw Thursday News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Hinshaw thursday. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Hinshaw Thursday Today - Breaking & Trending Today

NDP to continue push for paid sick leave when Alberta legislature returns Tuesday, virtual voting on the table


Article content
Paid sick leave will return to the spotlight Tuesday as the Alberta legislature returns after a three-week break.
The New Democrat Opposition has promised to continue to press the government to adopt a paid sick leave bill it has drafted but not had the opportunity to introduce in the legislature despite Premier Jason Kenney shutting down the idea last week.
We apologize, but this video has failed to load.
Try refreshing your browser, or
NDP to continue push for paid sick leave when Alberta legislature returns Tuesday, virtual voting on the table Back to video
NDP Deputy Leader Sarah Hoffman said Monday the policy is the Opposition’s highest priority, and they will be pushing for it in question period because Albertans desperately need it. ....

Sarah Hoffman , Rachel Notley , Lisa Johnson , Jason Kenney , Deena Hinshaw , Murray Sigler , Nathan Cooper , Calgary Chamber , Postmedia Network Inc , Citizen Initiative , David Bloom , New Democrat Opposition , Premier Jason Kenney , Leader Sarah Hoffman , Alberta Jobs Now , Hinshaw Thursday , Recall Act , Citizen Initiative Act , Postmedia Network , Street East , சாரா ஹாஃப்மேன் , ரேச்சல் நோட்லி , லிசா ஜான்சன் , ஜேசன் கெநீ , தீனா ஹின்ஷா , முர்ரே சிகிலேர் ,

Exclusive: Axcella Health Aims To Become The Standard Of Care


Share:
Axcella Health Inc (NASDAQ: AXLA) is a clinical-stage biotechnology company focused on endogenous metabolic modulators, or EEMs, said Axcella Health CEO Bill Hinshaw Thursday on Benzinga s YouTube show Power Hour.
Axcella Health has two rapidly progressing Phase II late-stage clinical development programs, he said. 
The company earlier announced Phase II clinical trials for its drug to treat nonalcoholic steatohepatitis, or NASH, which the CEO explained as a complex fatty liver disease, adding that more than 40 million Americans have it.
Hinshaw told Benzinga that NASH will be an $8 billion-plus market by 2027 and the company expects to be one of the leaders in the treatment of NASH.  ....

United States , Benzinga Youtube , Axcella Health Inc , Axcella Health , Hinshaw Thursday , ஒன்றுபட்டது மாநிலங்களில் ,